ACLX
Arcellx, Inc.
Arcellx, Inc. (ACLX) has 5 SEC Form 4 filings (10 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Apr 17, 2026.
Insiders have net sold $11.5M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Rami Elghandour
- Employees:163
- HQ:Redwood City, MD, US
- IPO:2022-02-04
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$11.5M
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
Elghandour RamiFirst filing | SEE REMARKS | Sale | 89,916 | $10.2M | Feb 27 | SEC ↗ |
Gilson MichelleFirst filing | CHIEF FINANCIAL OFFICER | Sale | 11,219 | $1.3M | Feb 25 | SEC ↗ |